Cargando…

Plasma Biomarkers of Alzheimer’s Disease in African Americans

BACKGROUND/OBJECTIVE: The aim of this study was to determine if plasma concentrations of 5 surrogate markers of Alzheimer’s disease (AD) pathology and neuroinflammation are associated with disease status in African Americans. METHODS: We evaluated 321 African Americans (159 AD, 162 controls) from th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deniz, Kaancan, Ho, Charlotte C.G., Malphrus, Kimberly G., Reddy, Joseph S., Nguyen, Thuy, Carnwath, Troy P., Crook, Julia E., Lucas, John A., Graff-Radford, Neill R., Carrasquillo, Minerva M., Ertekin-Taner, Nilüfer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902984/ https://www.ncbi.nlm.nih.gov/pubmed/33252078 http://dx.doi.org/10.3233/JAD-200828

Ejemplares similares

Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
por: Reddy, Joseph S., et al.
Publicado: (2022)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
por: Reddy, Joseph S., et al.
Publicado: (2021)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

Clinical Deep Phenotyping of ABCA7 Mutation Carriers
por: Campbell, Alana S., et al.
Publicado: (2022)

TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
por: Jin, Sheng Chih, et al.
Publicado: (2015)

Late-onset Alzheimer disease risk variants mark brain regulatory loci
por: Allen, Mariet, et al.
Publicado: (2015)

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions
por: Wang, Xue, et al.
Publicado: (2022)

Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbations
por: Patel, Tulsi, et al.
Publicado: (2022)

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013)

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort
por: Santos, Octavio A., et al.
Publicado: (2019)

Comparative evaluation for the globin gene depletion methods for mRNA sequencing using the whole blood-derived total RNAs
por: Jang, Jin Sung, et al.
Publicado: (2020)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases
por: Allen, Mariet, et al.
Publicado: (2016)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
por: Zou, Fanggeng, et al.
Publicado: (2012)

Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
por: Allen, Mariet, et al.
Publicado: (2018)

Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease
por: Ertekin-Taner, Nilüfer
Publicado: (2011)

Genetics of Alzheimer disease in the pre- and post-GWAS era
por: Ertekin-Taner, Nilüfer
Publicado: (2010)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease
por: Hanna Al-Shaikh, Fadi S., et al.
Publicado: (2019)

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
por: Allen, Mariet, et al.
Publicado: (2012)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
por: Oatman, Stephanie R., et al.
Publicado: (2023)

Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease
por: Crist, Angela M., et al.
Publicado: (2021)

Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
por: Min, Yuhao, et al.
Publicado: (2023)

The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer’s disease: A cross-sectional study
por: Matchett, Billie J., et al.
Publicado: (2023)

Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies
por: Wickland, Daniel P., et al.
Publicado: (2021)

Evaluation of the Role of SNCA Variants in Survival without Neurological Disease
por: Heckman, Michael G., et al.
Publicado: (2012)

Identification of missing variants by combining multiple analytic pipelines
por: Ren, Yingxue, et al.
Publicado: (2018)

MAPT haplotype–stratified GWAS reveals differential association for AD risk variants
por: Strickland, Samantha L., et al.
Publicado: (2020)

CWH43 Variants Are Associated With Disease Risk and Clinical Phenotypic Measures in Patients With Normal Pressure Hydrocephalus
por: Tipton, Philip W., et al.
Publicado: (2023)

Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease
por: Ertekin-Taner, Nilüfer, et al.
Publicado: (2013)

Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old
por: Lachner, Christian, et al.
Publicado: (2022)

Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight
por: Ebbert, Mark T. W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_df869ih2k4usroobji65redg64